Establishment
There is hereby established as an agency of Congress the Medicare Payment Advisory Commission (in this section referred to as the “Commission”).
Duties
Review of payment policies and annual reports
Specific topics to be reviewed
Medicare+Choice program
Original medicare fee-for-service system
Interaction of medicare payment policies with health care delivery generally
Specifically, the Commission shall review the effect of payment policies under this subchapter on the delivery of health care services other than under this subchapter and assess the implications of changes in health care delivery in the United States and in the general market for health care services on the medicare program.
Comments on certain secretarial reports
If the Secretary submits to Congress (or a committee of Congress) a report that is required by law and that relates to payment policies under this subchapter, the Secretary shall transmit a copy of the report to the Commission. The Commission shall review the report and, not later than 6 months after the date of submittal of the Secretary’s report to Congress, shall submit to the appropriate committees of Congress written comments on such report. Such comments may include such recommendations as the Commission deems appropriate.
Agenda and additional reviews
The Commission shall consult periodically with the chairmen and ranking minority members of the appropriate committees of Congress regarding the Commission’s agenda and progress towards achieving the agenda. The Commission may conduct additional reviews, and submit additional reports to the appropriate committees of Congress, from time to time on such topics relating to the program under this subchapter as may be requested by such chairmen and members and as the Commission deems appropriate.
Availability of reports
The Commission shall transmit to the Secretary a copy of each report submitted under this subsection and shall make such reports available to the public.
Appropriate committees of Congress
For purposes of this section, the term “appropriate committees of Congress” means the Committees on Ways and Means and Commerce of the House of Representatives and the Committee on Finance of the Senate.
Voting and reporting requirements
With respect to each recommendation contained in a report submitted under paragraph (1), each member of the Commission shall vote on the recommendation, and the Commission shall include, by member, the results of that vote in the report containing the recommendation.
Examination of budget consequences
Before making any recommendations, the Commission shall examine the budget consequences of such recommendations, directly or through consultation with appropriate expert entities.
Review and annual report on Medicaid and commercial trends
section 1396 of this titleThe Commission shall review and report on aggregate trends in spending, utilization, and financial performance under the Medicaid program under subchapter XIX and the private market for health care services with respect to providers for which, on an aggregate national basis, a significant portion of revenue or services is associated with the Medicaid program. Where appropriate, the Commission shall conduct such review in consultation with the Medicaid and CHIP Payment and Access Commission established under (in this section referred to as “MACPAC”).
Coordinate and consult with the Federal Coordinated Health Care Office
2
Interaction of Medicaid and Medicare
The Commission shall consult with MACPAC in carrying out its duties under this section, as appropriate. Responsibility for analysis of and recommendations to change Medicare policy regarding Medicare beneficiaries, including Medicare beneficiaries who are dually eligible for Medicare and Medicaid, shall rest with the Commission. Responsibility for analysis of and recommendations to change Medicaid policy regarding Medicaid beneficiaries, including Medicaid beneficiaries who are dually eligible for Medicare and Medicaid, shall rest with MACPAC.
Membership
Number and appointment
The Commission shall be composed of 17 members appointed by the Comptroller General.
Qualifications
In general
The membership of the Commission shall include individuals with national recognition for their expertise in health finance and economics, actuarial science, health facility management, health plans and integrated delivery systems, reimbursement of health facilities, allopathic and osteopathic physicians, and other providers of health services, and other related fields, who provide a mix of different professionals, broad geographic representation, and a balance between urban and rural representatives.
Inclusion
The membership of the Commission shall include (but not be limited to) physicians and other health professionals, experts in the area of pharmaco-economics or prescription drug benefit programs, employers, third-party payers, individuals skilled in the conduct and interpretation of biomedical, health services, and health economics research and expertise in outcomes and effectiveness research and technology assessment. Such membership shall also include representatives of consumers and the elderly.
Majority nonproviders
Individuals who are directly involved in the provision, or management of the delivery, of items and services covered under this subchapter shall not constitute a majority of the membership of the Commission.
Ethical disclosure
The Comptroller General shall establish a system for public disclosure by members of the Commission of financial and other potential conflicts of interest relating to such members. Members of the Commission shall be treated as employees of Congress for purposes of applying subchapter I of chapter 131 of title 5.
Terms
In general
The terms of members of the Commission shall be for 3 years except that the Comptroller General shall designate staggered terms for the members first appointed.
Vacancies
Any member appointed to fill a vacancy occurring before the expiration of the term for which the member’s predecessor was appointed shall be appointed only for the remainder of that term. A member may serve after the expiration of that member’s term until a successor has taken office. A vacancy in the Commission shall be filled in the manner in which the original appointment was made.
Compensation
section 5315 of title 5section 5948 of title 5While serving on the business of the Commission (including traveltime), a member of the Commission shall be entitled to compensation at the per diem equivalent of the rate provided for level IV of the Executive Schedule under ; and while so serving away from home and the member’s regular place of business, a member may be allowed travel expenses, as authorized by the Chairman of the Commission. Physicians serving as personnel of the Commission may be provided a physician comparability allowance by the Commission in the same manner as Government physicians may be provided such an allowance by an agency under , and for such purpose subsection (i) of such section shall apply to the Commission in the same manner as it applies to the Tennessee Valley Authority. For purposes of pay (other than pay of members of the Commission) and employment benefits, rights, and privileges, all personnel of the Commission shall be treated as if they were employees of the United States Senate.
Chairman; Vice Chairman
The Comptroller General shall designate a member of the Commission, at the time of appointment of the member as Chairman and a member as Vice Chairman for that term of appointment, except that in the case of vacancy of the Chairmanship or Vice Chairmanship, the Comptroller General may designate another member for the remainder of that member’s term.
Meetings
The Commission shall meet at the call of the Chairman.
Director and staff; experts and consultants
Powers
Obtaining official data
The Commission may secure directly from any department or agency of the United States information necessary to enable it to carry out this section. Upon request of the Chairman, the head of that department or agency shall furnish that information to the Commission on an agreed upon schedule.
Data collection
Access of GAO to information
The Comptroller General shall have unrestricted access to all deliberations, records, and nonproprietary data of the Commission, immediately upon request.
Periodic audit
The Commission shall be subject to periodic audit by the Comptroller General.
Authorization of appropriations
Request for appropriations
The Commission shall submit requests for appropriations in the same manner as the Comptroller General submits requests for appropriations, but amounts appropriated for the Commission shall be separate from amounts appropriated for the Comptroller General.
Authorization
There are authorized to be appropriated such sums as may be necessary to carry out the provisions of this section. Sixty percent of such appropriation shall be payable from the Federal Hospital Insurance Trust Fund, and 40 percent of such appropriation shall be payable from the Federal Supplementary Medical Insurance Trust Fund.
Aug. 14, 1935, ch. 531Pub. L. 105–33, title IV, § 4022(a)111 Stat. 350Pub. L. 105–277, div. J, title V, § 5202(a)112 Stat. 2681–917Pub. L. 106–113, div. B, § 1000(a)(6) [title II, § 211(a)(2)(B)]113 Stat. 1536Pub. L. 106–554, § 1(a)(6) [title V, § 544(a)(1), (b)]114 Stat. 2763Pub. L. 108–173, title VII, § 735(a)117 Stat. 2353Pub. L. 110–173, title III, § 301121 Stat. 2514Pub. L. 111–148, title II, § 2801(b)124 Stat. 332Pub. L. 115–123, div. E, title XI, § 52001(b)(3)132 Stat. 298Pub. L. 117–286, § 4(c)(41)136 Stat. 4359(, title XVIII, § 1805, as added , , ; amended , , ; , , , 1501A–347; , , , 2763A–551; –(c)(1), (e)(1), , , 2354; , , ; , title III, § 3403(c), , , 507; , , ; , , .)
Editorial Notes
References in Text
Pub. L. 111–148124 Stat. 119section 1315b(a)(1) of this titlesection 18001 of this titleThe Patient Protection and Affordable Care Act, referred to in subsec. (b)(10), is , , . The Act does not contain a section 2081. The Federal Coordinated Health Care Office is established in section 2602(a)(1) of the Act, which is classified to . For complete classification of this Act to the Code, see Short Title note set out under and Tables.
Codification
section 6101 of title 4141 U.S.C. 5Pub. L. 111–350, § 6(c)124 Stat. 3854In subsec. (d)(3), “” substituted for “section 3709 of the Revised Statutes ()” on authority of , , , which Act enacted Title 41, Public Contracts.
Amendments
Pub. L. 117–286Public Law 95–5212022—Subsec. (c)(2)(D). substituted “subchapter I of chapter 131 of title 5.” for “title I of the Ethics in Government Act of 1978 ().”
Pub. L. 115–1232018—Subsec. (b)(4) to (9). struck out par. (4), redesignated former pars. (5) to (8) as (4) to (7), respectively, and redesignated former par. (9) relating to examination of budget consequences as par. (8). Prior to amendment, par. (4) related to review and comment on proposals submitted to the Commission.
Pub. L. 111–148, § 2801(b)(1)2010—Subsec. (b)(1)(C). , substituted “March 15” for “March 1 of each year (beginning with 1998)”.
Pub. L. 111–148, § 2801(b)(2)Subsec. (b)(1)(D). , inserted “, and (beginning with 2012) containing an examination of the topics described in paragraph (9), to the extent feasible” before the period.
Pub. L. 111–148, § 3403(c)(2)Subsec. (b)(4). , added par. (4). Former par. (4) redesignated (5).
Pub. L. 111–148, § 3403(c)(1)Subsec. (b)(5) to (8). , redesignated pars. (4) to (7) as (5) to (8), respectively. Former par. (8) relating to examination of budget consequences redesignated (9).
Pub. L. 111–148, § 3403(c)(1)Subsec. (b)(9). , redesignated par. (8) relating to examination of budget consequences as (9).
Pub. L. 111–148, § 2801(b)(3), added par. (9) relating to review and annual report on Medicaid and commercial trends.
Pub. L. 111–148, § 2801(b)(3)Subsec. (b)(10), (11). , added pars. (10) and (11).
Pub. L. 110–1732007—Subsec. (a). inserted “as an agency of Congress” after “established”.
Pub. L. 108–173, § 735(b)2003—Subsec. (b)(2)(B)(i). , inserted “the efficient provision of” after “expenditures for”.
Pub. L. 108–173, § 735(a)Subsec. (b)(8). , added par. (8).
Pub. L. 108–173, § 735(e)(1)Subsec. (c)(2)(B). , inserted “experts in the area of pharmaco-economics or prescription drug benefit programs,” after “other health professionals,”.
Pub. L. 108–173, § 735(c)(1)Public Law 95–521Subsec. (c)(2)(D). , inserted at end “Members of the Commission shall be treated as employees of Congress for purposes of applying title I of the Ethics in Government Act of 1978 ().”
Pub. L. 106–554, § 1(a)(6) [title V, § 544(a)(1)]2000—Subsec. (b)(1)(D). , substituted “June 15 of each year,” for “June 1 of each year (beginning with 1998),”.
Pub. L. 106–554, § 1(a)(6) [title V, § 544(b)]Subsec. (b)(7). , added par. (7).
Pub. L. 106–113section 1395w–4(d)(1)(E)(ii) of this title1999—Subsec. (b)(1)(D). inserted “and including a review of the estimate of the conversion factor submitted under ” before period at end.
Pub. L. 105–2771998—Subsec. (c)(1). substituted “17” for “15”.
Statutory Notes and Related Subsidiaries
Change of Name
section 201 of Pub. L. 108–173section 1395w–21 of this titleReferences to Medicare+Choice deemed to refer to Medicare Advantage or MA, subject to an appropriate transition provided by the Secretary of Health and Human Services in the use of those terms, see , set out as a note under .
Effective Date of 2003 Amendment
Pub. L. 108–173, title VII, § 735(c)(2)117 Stat. 2354
Effective Date of 2000 Amendment
Pub. L. 106–554, § 1(a)(6) [title V, § 544(a)(2)]114 Stat. 2763
Effective Date of 1999 Amendment
Pub. L. 106–113section 1395w–4(d) of this titlePub. L. 106–113section 1395w–4 of this titleAmendment by effective in determining conversion factor under for years beginning with 2001 and not applicable to or affecting any update (or any update adjustment factor) for any year before 2001, see section 1000(a)(6) [title II, § 211(d)] of , set out as a note under .
Effective Date; Transition; Transfer of Functions
Pub. L. 105–33, title IV, § 4022(c)111 Stat. 355
In general .—
Transition .—
Continuing responsibility for reports .—
MedPAC Review of Payments to Rural Emergency Hospitals
Pub. L. 116–260, div. CC, title I, § 125(f)134 Stat. 2966
Appointment of Experts in Prescription Drugs
Pub. L. 108–173, title VII, § 735(e)(2)117 Stat. 2354
MedPAC Analysis of Impact of Volume on Per Unit Cost of Rural Hospitals With Psychiatric Units
Pub. L. 106–554, § 1(a)(6) [title II, § 214]114 Stat. 2763
MedPAC Study on Complexity of Medicare Program and Levels of Burdens Placed on Providers Through Federal Regulations
Pub. L. 106–113, div. B, § 1000(a)(6) [title II, § 229(c)]113 Stat. 1536, , , 1501A–357, required a comprehensive study related to regulatory burdens placed on health care providers and, no later than , a report and legislative recommendations.
MedPAC Report
Pub. L. 106–113, div. B, § 1000(a)(6) [title III, § 312(c)]113 Stat. 1536
MedPAC Study of Rural Providers
Pub. L. 106–113, div. B, § 1000(a)(6) [title IV, § 411]113 Stat. 1536, , , 1501A–377, required a study evaluating the adequacy and appropriateness of the categories of special payments established for rural hospitals under the medicare program and a report to be submitted no later than 18 months after .
Quality Improvement Standards
Pub. L. 106–113, div. B, § 1000(a)(6) [title V, § 520(c)]113 Stat. 1536
Study .—
Considerations .—
Report .—
Initial Terms of Additional Members
Pub. L. 105–277, div. J, title V, § 5202(b)112 Stat. 2681–917
In general .—
Commencement of terms .—
Information Included in Annual Recommendations
Pub. L. 105–33, title IV, § 4804(c)111 Stat. 552